Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Steven P. Richieri
Observed names:
S P Richieri,
S. P. Richieri,
S. Richieri,
STEVEN P. RICHIERI,
Steven P Richieri,
Steven P. Richieri
show all 6
Institutions:
Stiftelsen Norsk Luftambulanse,
Banyan Biomarkers (United States)
Observed institutions:
University of Southern California,
Naval Medical Center San Diego,
Salk Institute for Biological Studies,
Stiftelsen Norsk Luftambulanse,
Graduate Hospital,
Banyan Biomarkers (United States),
University of Pennsylvania
show all 7
OpenAlex ID:
A5028440295
Transcranial Laser Therapy in Acute Stroke Treatment: Results of Neurothera Effectiveness and Safety Trial 3, a Phase III Clinical End Point Device Trial
2014
·
Werner Hacke
, Peter D. Schellinger
, et al.
·
Stroke
·
148
PDF
Insight into Pre-Clinical Models of Traumatic Brain Injury Using Circulating Brain Damage Biomarkers: Operation Brain Trauma Therapy
2015
·
Stefania Mondello
, Deborah A. Shear
, et al.
·
Journal of Neurotrauma
·
82
T cell receptor peptide vaccination in rheumatoid arthritis: A placebo-controlled trial using a combination of V3, V14, and V17 Peptides
1998
·
Larry W. Moreland
, Elizabeth E. Morgan
, et al.
·
Arthritis & Rheumatism
·
76
Effect of Immunization with Inactivated gp120-Depleted Human Immunodeficiency Virus Type 1 (HIV-1) Immunogen on HIV-1 Immunity, Viral DNA, and Percentage of CD4 Cells
1994
·
R. J. Trauger
, F. Ferre
, et al.
·
The Journal of Infectious Diseases
·
75
Initial Studies on Active Immunization of HIV-Infected Subjects Using a gp120-Depleted HIV-1 Immunogen: Long-Term Follow-Up
1996
·
Alexandra M. Levine
, Susan Groshen
, et al.
·
Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology
·
63
Synthesis of Findings, Current Investigations, and Future Directions: Operation Brain Trauma Therapy
2015
·
Patrick M. Kochanek
, Helen M. Bramlett
, et al.
·
Journal of Neurotrauma
·
60
Diagnostic Accuracy of Glial Fibrillary Acidic Protein and Ubiquitin Carboxy-Terminal Hydrolase-L1 Serum Concentrations for Differentiating Acute Intracerebral Hemorrhage from Ischemic Stroke
2020
·
for the BE FAST III Study Group
, Sebastian Luger
, et al.
·
Neurocritical Care
·
59
Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRVβ6 CDR2 peptide
1997
·
Daniel P Gold
, Richard A Smith
, et al.
·
Journal of Neuroimmunology
·
58
Long-Term Safety of Single and Multiple Infrared Transcranial Laser Treatments in Sprague–Dawley Rats
2010
·
Thomas J. McCarthy
, Luis De Taboada
, et al.
·
Photomedicine and Laser Surgery
·
52
Characterization of highly purified, inactivated HIV-1 particles isolated by anion exchange chromatography
1998
·
Steven P. Richieri
, Richard Bartholomew
, et al.
·
Vaccine
·
50
V beta 17 T cell receptor peptide vaccination in rheumatoid arthritis: results of phase I dose escalation study.
1996
·
L W Moreland
, L W Heck
, et al.
·
PubMed
·
43
Effect of Immunization With an Inactivated gp120-Depleted HIV-1 Immunogen on β-Chemokine and Cytokine Production in Subjects With HIV-1 Infection
1997
·
Ronald B. Moss
, Richard J. Trauger
, et al.
·
Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology
·
30
Phenotypic Analysis of Human Immunodeficiency Virus (HIV) Type 1 Cell‐Mediated Immune Responses after Treatment with an HIV‐1 Immunogen
1999
·
Ronald B. Moss
, Mark R. Wallace
, et al.
·
The Journal of Infectious Diseases
·
29
Cross-Clade Immune Responses after Immunization with a Whole-Killed gp120-Depleted Human Immunodeficiency Virus Type-1 Immunogen in Incomplete Freund's Adjuvant (HIV-1 Immunogen, Remune™) in Human Immunodeficiency Virus Type-1 Seropositive Subjects
1997
·
RONALD B. MOSS
, WIESLAWA GIERMAKOWSKA
, et al.
·
Viral Immunology
·
27
In Vitro p24 Antigen-Stimulated Lymphocyte Proliferation and β-Chemokine Production in Human Immunodeficiency Virus Type 1 (HIV-1)-Seropositive Subjects after Immunization with an Inactivated gp120-Depleted HIV-1 Immunogen (Remune)
1998
·
Ronald B. Moss
, Mark R. Wallace
, et al.
·
Clinical and Diagnostic Laboratory Immunology
·
25
Viral load in peripheral blood mononuclear cells as surrogate for clinical progression.
1995
·
F Ferre
, R B Moss
, et al.
·
PubMed
·
22
Viral load, CD4 percentage, and delayed-type hypersensitivity in subjects receiving the HIY-1 Immunogen and antiviral drug therapy
1996
·
Ronald B. Moss
, Francois Ferre
, et al.
·
Journal of Clinical Immunology
·
20
Development and validation of a polymerase chain reaction method for the precise quantitation of HIV-1 DNA in blood cells from subjects undergoing a 1-year immunotherapeutic treatment
1993
·
Francois Ferre
, Ana L. Marchese
, et al.
·
AIDS
·
17
A primer on HIV type 1-specific immune function and REMUNE.
1998
·
R B Moss
, W K Giermakowska
, et al.
·
PubMed
·
16
Inactivated HIV-1 Immunogen: impact on markers of disease progression.
1994
·
R B Moss
, F Ferré
, et al.
·
PubMed
·
11
Results of a Phase II Rheumatoid Arthritis Clinical Trial Using T-Cell Receptor Peptides
1999
·
S. W. Brostoff
, D. J. Carlo
, et al.
·
Springer eBooks
·
10
Tumor necrosis factor alpha and human immunodeficiency virus-specific functional immune responses after immunization with Gp120-depleted, inactivated HIV-1 in incomplete Freund's adjuvant (REMUNE) in HIV-1-seropositive subjects.
1998
·
R B Moss
, L Li
, et al.
·
PubMed
·
8
HIV-1-Specific Functional Immune Measurements as Markers of Disease Progression
1997
·
Ronald B. Moss
, Steven P. Richieri
, et al.
·
Journal of Biomedical Science
·
7
Whole-killed gp120-depleted HIV-1 antigen in a murine model for prophylactic vaccination
1998
·
Paola Lanza
, Ronald B. Moss
, et al.
·
Vaccine
·
4
Combination Therapies Against HIV-1 Infection: Exploring the Concept of Combining Antiretroviral Drug Treatments with HIV-1 Immune-Based Therapies in Asymptomatic Individuals. . .
1996
·
Francois Ferre
, Ronald B. Moss
, et al.
·
AIDS Patient Care and STDs
·
3
Show more works
View as search
Works count:
29
Citation count:
996
H-index:
17
I10-index:
21
Year
Topic
Type